INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
MYCOTA POWDER

This file is based on:
THE APPROVED LABEL: THE PACKAGE INSERT BEING AN INTEGRAL PART OF THE LABEL

SCHEDULING STATUS:
Unscheduled.

PROPRIETARY NAME
(and dosage form):

MYCOTA POWDER

COMPOSITION:
Contains Zinc undecenoate 200 mg/g and Undecenoic acid 20 mg/g.

PHARMACOLOGICAL CLASSIFICATION:
{A/13.9.2/Dermatological preparations. Fungicides.}

PHARMACOLOGICAL ACTION:
Mycota Powder contains 2 anti-fungal agents that kill the fungi responsible for athletes foot and other fungal infections of the skin.

INDICATIONS:
Athletes foot and other fungal infections of the skin.
Mycota Powder can be used in conjunction with Mycota Cream & Spray.

CONTRA-INDICATIONS:
{None stated}

DOSAGE AND DIRECTIONS FOR USE:
Wash and thoroughly dry the affected area and liberally sprinkle on Mycota Powder paying particular attention to the areas between the toes. Use morning and night.
Treatment should be continued for at least one week after all evidence of infection has disappeared.

PREVENTION: Mycota Powder may be dusted into the socks or applied freely to the feet each day after they have been carefully washed and dried.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
FOR EXTERNAL USE ONLY.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Treatment is symptomatic when accidentally ingested.

IDENTIFICATION:
-

PRESENTATION:
50 g

STORAGE INSTRUCTIONS:
KEEP OUT OF REACH OF CHILDREN.
Store below 25°C.

REFERENCE NUMBER:
G 1684 (Act/Wet 101/1965)

NAME AND BUSINESS ADDRESS OF APPLICANT:
THE BOOTS COMPANY (SOUTH AFRICA) (PTY) LTD.
Electron Avenue/-Laan, Isando 1600

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
{not stated}
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2000